Viruses and autoimmune diseases

Scandinavian Journal of Immunology

Volumn 46, Issue 4, 1997, Pages 320-325

  Oldstone, M B A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; CYTOSKELETON PROTEIN; MYELIN BASIC PROTEIN;

ALLERGIC ENCEPHALITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AUTOIMMUNITY; CONTROLLED STUDY; COXSACKIE VIRUS B; DNA VIRUS; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; REVIEW; RNA VIRUS; RUBELLA VIRUS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; VIRUS INFECTION;

EID: 0030862789     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1997.d01-145.x     Document Type: Review

References (53)

1. Oldstone MBA. Overview: Infectious agents as etiologic triggers of autoimmune disease. Curr Topics Microbiol Immunol 1989;145:1-3.
2. Oldstone MBA. Molecular mimicry as a mechanism for the cause and as a probe uncovering etiologic agent(s) of autoimmune disease. Curr Topics Microbiol Immunol 1989;145:127-35.
3. Notkins AL, Onodera T, Prabhakar B. Virus induced autoimmunity. In: Notkins AL, Oldstone MBA, eds. Concepts in Viral Pathogenesis. Heidelberg: Springer-Verlag, 1984:210-15.
4. von Herrath MG, Evans CF, Horwitz MS, Oldstone MBA. Using transgenic mouse models to dissect the pathogenesis of virus-induced autoimmune disorders of the islets of Langerhans and the central nervous system. Immunol Rev 1996;152:111-43.
5. von Herrath MG, Oldstone MBA. Virus-induced autoimmune disease. Curr Opin Immunol 1996;8:878-85.
6. Oldstone MBA, Nerenberg M, Southern P, Price J, Lewicki H. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 1991;65:319-31.
7. Ohashi P, Oehen S, Buerki K et al. Ablation of tolerance and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991;65:305-17.
8. Rocken M, Urban J, Shevach E. Infection breaks T-cell tolerance. Nature 1992;359:79-80.
9. Lee M-S, von Herrath M, Reiser H, Oldstone MBA, Sarvetnick N. Sensitization to self antigens by in situ expression of interferon-γ. J Clin Invest 1995;95:486-92.
10. von Herrath MG, Guerder S, Lewicki H, Flavell R, Oldstone MBA. Co-expression of B7.1 and viral (self) transgenes in pancreatic β-cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes. Immunity 1995;3:727-38.
11. Ohashi P, Oehen S, Aichele P et al. Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and TNF-α. J Immunol 1993;150:5185-94.
12. von Herrath MG, Oldstone MBA. Interferon-γ is essential for destruction of β cells and development of insulin-dependent diabetes meliitus. J Exp Med 1997;185:531-9.
13. Gamble DR, Taylor KW, Cumming H. Coxsackie viruses and diabetes mellitus. Brit Med J 1973;4:260-2.
14. Forrest JM, Menser MA, Burgess JA. High frequency of diabetes mellitus in young adults with congenital rubella. Lancet 1971;8:332.
15. Oldstone MBA, Notkins AL. Molecular mimicry. In: Notkins AL, Oldstone MBA, eds. Concepts in Viral Pathogenesis II. Springer-Verlag, New York, 1986:195-202.
16. Yoon J, Austin M, Onodera T, Notkins AL. Virus-induced diabetes mellitus. N Engl J Med 1979;300:1173.
17. Lane DP, Hoeffler WK. SV40 large T shares an antigenic determinant with a cellular protein of molecular weight 68,000. Nature 1980;288:167-70.
18. Fujinami RS, Oldstone MBA, Wroblewska Z, Frankel ME, Koprowski H. Molecular mimicry in virus infection: Cross-reaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci USA 1983;80:2346-50.
19. Dales S, Fujinami RS, Oldstone MBA. Infection with vaccinia favors the selection of hybridomas synthesizing auto-antibodies against intermediate filaments, among them one cross-reacting with the virus hemagglutinin. J Immunol 1983;131:1546-53.
20. Srinivasappa J, Saegusa J, Prabhakar BS et al. Molecular mimicry: Frequency of reactivity of monoclonal antiviral antibodies with normal tissues. J Virol 1986;57:397-401.
21. Oldstone MBA. Molecular mimicry and autoimmune disease. Cell 1987;50:819-20.
22. Wucherpfennig KW, Strominger JL. Molecular mimicry in T-cell mediated autoimmunity: viral peptides activate human T-cell clones specific for myelin basic protein. Cell 1995;80:695-705.
23. Talbot PJ, Paquette J-S, Ciurli C, Antel JP, Quellet F. Myelin basic protein and human corona virus 229E: Cross-reactive T cells in multiple sclerosis. Ann Neurol 1986;39:233-40.
24. Banki K, Colombo E, Sia F et al. Oligodendrocyte-specific expression and autoantigenicity in transaldolase in multiple sclerosis. J Exp Med 1994;180:1649-63.
25. Colombo E, Banki K, Tatum AH et al. Comparative analysis of antibody and cell-mediated autoimmunity to transaldolase and myelin basic protein in patients with multiple sclerosis. J Clin Invest 1997;99:1238-50.
26. Tian J, Lehmann PV, Kaufman DL. T cell cross-reactivity between coxsackievirus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. J Exp Med 1994;180:1979-84.
27. Atkinson MK, Bowman MA, Campbell L, Darrow BL, Kaufman DL, Maclaren NK. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest 1994;94:2125-9.
28. Bjorkman PJ, Saper MA, Samraoui B, Bennet WS, Strominger JL, Wiley DC. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987;329:506-11.
29. Garcia KC, Degano M, Stanfield RL et al. The alphabeta T cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex. Science 1996;274:209-19.
30. b molecules is controlled by dominant negative elements at peptide non-anchor residues: Implications for peptide selection and presentation. J Biol Chem 1996;271:17829-36.
31. Sette A, Alexander J, Ruppert J et al. Antigen analogs/MHC complexes as specific T cell receptor antagonists. Ann Rev Immunol 1994;12:413-31.
32. Kersh GJ, Allen PM. Essential flexibility in the T-cell recognition of antigen. Nature 1996;380:495-8.
33. Tallquist MD, Yun TJ, Pease LR. A single T cell receptor recognizes structurally distinct MHC/peptide complexes with high specificity. J Exp Med 1996;184:1017-26.
34. Herman A, Kappler JW, Marrack P, Pullen AM. Superantigens: mechanism of T-cell stimulation and role in immune responses. Ann Rev Immunol 1991;9:745-72.
35. Evavold BD, Sloan-Lancaster J, Wilson KJ, Rothbard JB, Allen PM. Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity 1995;2:655-63.
36. Fujinama RS, Oldstone MBA. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 1985;230:1043-5.
37. Neu N, Rose NR, Beisel KW, Herskowitz A, Gum-Glass G, Craig S. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 1987;139:3630-6.
38. O'Donoghue HL, Lawson CM, Reed WD. Autoantibodies to cardiac myosin in mouse cytomegalovirus myocarditis. Immunology 1990; 71:20-8.
39. von Herrath M, Dockter J, Oldstone MBA. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity 1994;1:231-42.
40. Mueller R, von Herrath M, Oldstone MBA, Sarvetnick N. Expression of 1L-4 in β cells of the islets of Langerhans aborts insulin dependent diabetes mellitus in a transgenic model. Manuscript submitted, 1997.
41. Evans CF, Horwitz MS, Hobbs MV, Oldstone MBA. Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease. J Exp Med 1996;184:2371-84.
42. von Herrath MG, Dockter J, Nerenberg M, Gairin JE, Oldstone MBA. Thymic selection and adaptability of cytotoxic T lymphocyte responses in transgenic mice expressing a viral protein in the thymus. J Exp Med 1994;180:1901-10.
43. Kagi D, Odermatt B, Ohashi PS, Zinkernagel RM, Hengartner H. Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity. J Exp Med 1996;183: 2143-52.
44. von Herrath M, Oldstone MBA. Molecules involved in β cell destruction. Submitted, 1997.
45. Ohashi PS, Oehen S, Aichele P et al. Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-alpha. J Immunol 1993;150:5185-94.
46. von Herrath MG, Dyrberg T, Oldstone MBA. Oral insulin treatment suppresses virus-induced antigen-specific destruction of β cells and prevents autoimmune diabetes in transgenic mice. J Clin Invest 1996;98:1327-31.
47. von Herrath MG, Coon B, Mazarguil H, Gairin JE, Oldstone MBA. A specific MHC class I restricted "blocking peptide" prevent activation of virus-induced CTL and the development of virus-induced autoimmune diabetes. J Exp Med 1997: submitted.
48. von Herrath MG, Efrat S, Oldstone MBA, Horwitz MS. Expression of adenoviral E3 transgenes in β-cells prevents autoimmune diabetes. PNAS 1997; in press.
49. Homann D, Dyrberg T, Oldstone MBA, von Herrath M. A single amino acid change in the B-chain of insulin completely abrogates the efficacy of this compound to induce "oral tolerance" and prevent autoimmune diabetes. Manuscript submitted, 1997.
50. Homann D, Dyrberg T, Oldstone MBA, von Herrath M. A single amino acid change in the B-chain of insulin completely abrogates the efficacy of this compound to induce "oral tolerance" and prevent autoimmune diabetes. Abstract: 21st Annual Conference of the La Jolla Immunologists, The Scripps Research Institute, La Jolla, CA, Nov. 7-8, 1996.
51. Gairin JE, Oldstone MBA. Design of high-affinity major histocompatibility complex-specific antagonist peptides that inhibit cytotoxic T-lymphocyte activity: Implications for control of viral disease. J Virol 1992;66:6755-62.
52. Ebers GC. Multiple sclerosis and other demyelinating diseases. In: Asbury, McKann, McDonald, eds. Diseases of the Nervous System. W.B. Saunders Co., Philadelphia. 1986:1268-81.
53. Kurtzke JF. Epidemiologie contributions to multiple sclerosis: An overview. Neurology 1986;30:61-79.